Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Combined Use of Niraparib Enhanced the Inhibitory Effect of Anti-GD2 Antibody on Osteosarcoma Cells

Fantahun Abza Babeta*, Anteneh Belachew Fantaye and Yared Getachew Mekonnen
*Corresponding Author:

Received Date: Apr 02, 2024 / Published Date: May 03, 2024

Copyright: © 2024  . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 
To read the full article Peer-reviewed Article PDF image

Abstract

Purpose: To study the inhibitory effect of Niraparib in combination with Anti-GD2 antibody on Osteosarcoma. Methods: The migration ability of OS cells was detected by scratch test. Transwell experiment and CCK8 assay were used to detect the invasion and proliferation. WB was used to detect BALP and CICP protein expression. The mRNA expression of BALP and CICP was detected by QRT-PCR. Results: Scratch test showed that the distance between cells in Niraparib+GD2 group was 1.07 ± 0.04 and 1.06 ± 0.04 at 48 h, both p<0.05, and the differences were statistically significant. Transwell experiment showed that the number of invasive cells was 21 ± 1.5 in Niraparib+GD2 group, p ​

Keywords

Top